N-(氰甲基)-4-(2-((4-(3-氧代吗啉基)苯基)氨基)嘧啶-4-基)苯甲酰胺(1841094-23-2)名称与标识符
名称
英文别名：
1841094-23-2;1841094-23-2;GCOZTZVZABCZPR-UHFFFAOYSA-N;GCOZTZVZABCZPR-UHFFFAOYSA-N;CHEMBL4470855;CHEMBL4470855;Momelotinib impurity 7;Momelotinib impurity 7;N-(cyanomethyl)-4-(2-{[4-(3-oxomorpholin-4-yl)phenyl]amino}pyrimidin-4-yl)benzamide;N-(cyanomethyl)-4-(2-{[4-(3-oxomorpholin-4-yl)phenyl]amino}pyrimidin-4-yl)benzamide;Momelotinib metabolite M21;Momelotinib metabolite M21;4'-Desmorpholino,-4'-morpholin-3-on-4-yl Momelotinib;4'-Desmorpholino,-4'-morpholin-3-on-4-yl Momelotinib;98KDC0ZGX2;98KDC0ZGX2;N-(Cyanomethyl)-4-(2-((4-(3-oxo-4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide;N-(Cyanomethyl)-4-(2-((4-(3-oxo-4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide;SCHEMBL17332920;SCHEMBL17332920;Benzamide, N-(cyanomethyl)-4-(2-((4-(3-oxo-4-morpholinyl)phenyl)amino)-4-pyrimidinyl)-;Benzamide, N-(cyanomethyl)-4-(2-((4-(3-oxo-4-morpholinyl)phenyl)amino)-4-pyrimidinyl)-;UNII-98KDC0ZGX2;UNII-98KDC0ZGX2;
标识符
InChIKey：
GCOZTZVZABCZPR-UHFFFAOYSA-N
Inchi：
1S/C23H20N6O3/c24-10-12-25-22(31)17-3-1-16(2-4-17)20-9-11-26-23(28-20)27-18-5-7-19(8-6-18)29-13-14-32-15-21(29)30/h1-9,11H,12-15H2,(H,25,31)(H,26,27,28)
SMILES：
O=C(C1C=CC(C2C=CN=C(NC3C=CC(N4C(=O)COCC4)=CC=3)N=2)=CC=1)NCC#N
